External Grants Projects

Project_Number

Title

Principal_Investigator

Email

Funding_Body_Type

Funding_Body

Theme

EG/AGR/CROP/16/01

Establishment of a Culture Collection of Fungi at SQU

Abdullah Al Saadi

alsadi@squ.edu.om

Public Sector

TRC

EBR

Project_Number

Title

Principal_Investigator

Email

Funding_Body_Type

Funding_Body

Theme

EG/AGR/ANVS/15/01

Determination of the Chemical Composition of the Crushed Date Palm Fronds and Cull Dates

Osman Gaafar

Osmahgob@squ.edu.om

Private Sector

Qatar University / National Properties Research Program( NPRP )

EBR

EG/MED/CHLD/15/01

Epidemiology & Characteristics of Childhood Leukemia in Oman

Zakiya Al - Lamki

zakiya.allamki@gmail.com

Private Sector

The Terry Fox Foundation

LHS

 

Project_Number

Title

Principal_Investigator

Email

Funding_Body_Type

Funding_Body

Theme

EG/AGR/SWAE/14/01

 

Dr. Salim Al Jabri

salemj@squ.edu.om

Public Sector

Agriculture and Fisheries Development Fund

FUR

EG/MED/CHLD/14/05

An Observational, Multi Center Study to Evaluate the Safety of Deferasirox in the Treatment of Paediatric Patients with Non-Transfusion Dependent Iron Overload

Prof. Dr. Yasser Wali

yawali@squ.edu.om

Private Sector

Novartis Pharma Services AG

LHS

EG/AGR/FISH/14/01

Bioluminescent Field of the Omani Coastal Waters

Dr.Sergey Piontkovski

spion@squ.edu.om

Private Sector

Office of Noval Research(USA)

EBR

EG/DVC/EMC/14/01

Seismic Array investigation in Al-Rustag Region

Dr. Issa Al Hussain

elhussain@squ.edu.om

Private Sector

Lawrence Livermore National Laboratory, USA

EBR

EG/DVC/WRC/14/02

Managed Aquifer Recharge using Treated Wastewater in Different Geological Settings of MENA countries

Dr.Ali Al Maktoumi

ali4530@squ.edu.om

Private Sector

Futher Advancing the Blue Revolution Intitiative

EBR

EG/MED/CHLD/14/04

An open label study to evaluate prophylaxis, treatment and to characterize the efficacy, safety and phamacokinetics of B-domain deleted recombinant factor VIII al bumin free in children with hemophilia

Prof. Yasser Wali

yasser_wali@squ.edu.om

Private Sector

PAREXEL International GmbH

LHS

EG/MED/CHLD/14/03

A multi-Country epidemiology study to identify Predictors associated with RSV hospitalization in Non-prophylaxed premature Infants born between 33 weeks and 0days and 35 weeks and 6 days of gestation

Dr. Hussain Al Kindi

husseink@squ.edu.om

Private Sector

AbbVie Biopharmaceuticals

LHS

EG/MED/HAEM/14/01

A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial of MST-188 (purified poloxamer 188) Injection in Children with Sickle Cell Disease Experiencing Vaso-occlusive Crisis

Murtadha Al Khabori

khabori@squ.edu.om

Private Sector

MastTherapeutics Inc.

LHS

EG/MED/CHLD/14/02

A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial of MST-188 (purified poloxamer 188) Injection in Children with Sickle Cell Disease Experiencing Vaso-occlusive Crisis

Yasser Wali

yawali@squ.edu.om

Private Sector

MastTherapeutics Inc.

LHS

EG/MED/CHLD/14/01

KAPPA (Key Aspects of medical Practice in Patients with Haemophilia A)

Yasser Wali

yawali@squ.edu.om

Private Sector

Kantar Health Egypt

LHS

EG/DVC/WRC/14/01

Application of near-real time monitoring systems for irrigated agriculture in MENA

Yaseen A. Al-Mulla

yalmula@squ.edu.om

Private Sector

Futher Advancing the Blue Revolution Intitiative

EBR